Kolexia
Conroy Thierry Oncologie médicale
Conroy Thierry
Oncologie médicale
Institut de cancérologie de Lorraine
Vandoeuvre-lès-Nancy, France
236 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du pancréas Adénocarcinome Tumeurs du rectum Tumeurs du sein Fatigue Tumeurs de l'oesophage Tumeurs colorectales Carcinomes Métastase tumorale

Collaborateurs

Voir plus
Bouche Olivier
Bouche Olivier
Hôpital Robert-Debré Reims, Reims, France
Francois Eric
Francois Eric
Centre Antoine Lacassagne, Nice, France
Ducreux Michel
Ducreux Michel
Gustave-Roussy, Villejuif, France
Ychou Marc
Ychou Marc
Icm Montpellier, Montpellier, France

Industries

Voir plus
VIATRIS MEDICAL
2 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Essai Clinique (National Cancer Institute)   20 mars 2024
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery: A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Essai Clinique (National Cancer Institute)   08 mars 2024
The role of total neoadjuvant therapy in locally advanced rectal cancer: a survey of specialists attending the All-Ireland Colorectal Cancer Conference 2022 including lead investigators of OPRA, PRODIGE-23 and RAPIDO.
Irish journal of medical science   23 décembre 2023
Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial.
Journal of the National Comprehensive Cancer Network : JNCCN   16 décembre 2023
Development and psychometric evaluation of item banks for memory and attention - supplements to the EORTC CAT Core instrument.
Health and quality of life outcomes   15 novembre 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   14 novembre 2023
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology   16 octobre 2023
Moving toward Precision Oncology Centers V2.0.
Annals of oncology : official journal of the European Society for Medical Oncology   05 octobre 2023
Organ preservation in rectal cancer treated by induction chemotherapy followed by chemoradiotherapy versus chemotherapy alone: Results from GRECCAR12 randomized phase 3 trial
ESCP\u0027s 18th Scientific and Annual Conference, 27–29 September 2023, LITEXPO in Vilnius, Lithuania   04 octobre 2023
COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19).
Cancers   28 septembre 2023